Published in J Neurol Sci on September 01, 1981
Restriction enzyme analysis of the mitochondrial genome in mitochondrial myopathy. J Med Genet (1988) 1.10
Respiratory chain defects in the mitochondria of cultured skin fibroblasts from three patients with lacticacidemia. J Clin Invest (1986) 1.07
Familial NADH: Q1 oxidoreductase (complex I) deficiency: variable expression and possible treatment. J Inherit Metab Dis (1989) 0.95
Gluconeogenesis in the perfused rat liver. Biochem J (1966) 8.58
Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst (2000) 5.14
Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature (1991) 5.04
The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry (1970) 4.50
Prevention of cardiovascular disease in general practice: a proposed model. Br Med J (Clin Res Ed) (1986) 3.56
Examination of a case of suspected McArdle's syndrome by 31P nuclear magnetic resonance. N Engl J Med (1981) 3.00
Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia (2001) 2.97
Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res (1997) 2.96
Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med (1993) 2.59
Muscular dystrophy in an X; 1 translocation female suggests that Duchenne locus is on X chromosome short arm. J Med Genet (1979) 2.57
The effect of oral contraceptives on migraine. Lancet (1966) 2.52
Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci U S A (2000) 2.49
Metabolic activities of the isolated perfused rat kidney. Biochem J (1967) 2.41
Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology (1995) 2.20
Ultra-fast three dimensional imaging of hyperpolarized 13C in vivo. MAGMA (2005) 2.17
Carbohydrate metabolism of the perfused rat liver. Biochem J (1967) 2.08
Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology (1992) 2.07
Choroid plexus papillomas: an immunohistological study of 16 cases. Histopathology (1989) 2.06
3-D FLASH imaging using a single surface coil and a new adiabatic pulse, BIR-4. Invest Radiol (1990) 1.88
Sodium reabsorption in the perfused rat kidney. Am J Physiol (1973) 1.82
Brief report: organic osmolytes in the brain of an infant with hypernatremia. N Engl J Med (1994) 1.81
Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem (2002) 1.74
Miraculous deliverance of Anne Green: an Oxford case of resuscitation in the seventeenth century. Br Med J (Clin Res Ed) (1983) 1.74
Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia (2000) 1.72
A mitochondrial myopathy characterized by a deficiency in reducible cytochrome b. Brain (1977) 1.69
Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J Neurochem (1994) 1.67
Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J Neurochem (1995) 1.66
Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels. Ann Clin Biochem (1997) 1.63
Enzyme distribution along the nephron. Kidney Int (1984) 1.60
Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology (1993) 1.58
Tricarboxylic acid cycle of glia in the in vivo human brain. NMR Biomed (2002) 1.57
Chloroquine myopathy. Q J Med (1971) 1.56
Patterns of referred pain in the normal subject. Brain (1967) 1.53
Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta (1999) 1.52
Diagnostic value of succinate ubiquinone reductase activity in the identification of patients with mitochondrial DNA depletion. J Inherit Metab Dis (2002) 1.51
Relief of severe intractable pain by barbotage of cerebrospinal fluid. Lancet (1972) 1.50
Blood mononuclear cell coenzyme Q10 concentration and mitochondrial respiratory chain succinate cytochrome-c reductase activity in phenylketonuric patients. J Inherit Metab Dis (2002) 1.47
Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology (1992) 1.47
Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy. Toxicol Lett (2001) 1.44
Superficial siderosis of the central nervous system. A report on nine cases with autopsy. Acta Neuropathol (1969) 1.43
Induction of cytotoxic oxidative stress by D-alanine in brain tumor cells expressing Rhodotorula gracilis D-amino acid oxidase: a cancer gene therapy strategy. Hum Gene Ther (1998) 1.43
Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy. Gene Ther (2000) 1.42
31P NMR examination of two patients with NADH-CoQ reductase deficiency. Nature (1982) 1.37
Spinal cord ischemia due to arteriosclerosis. Arch Neurol (1966) 1.33
Diffusion imaging for evaluation of tumor therapies in preclinical animal models. MAGMA (2004) 1.33
Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J Neurochem (1997) 1.33
Prospective comparison of modified fat-high-carbohydrate with standard low-carbohydrate dietary advice in the treatment of diabetes: one year follow-up study. Br J Nutr (1978) 1.32
Thrombosis of the posterior spinal arteries. A complication of an intrathecal injection of phenol. Neurology (1970) 1.31
Cerebral artery spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage. J Neurosurg (1978) 1.30
Ponto-bulbar palsy with deafness (Brown-Vialetto-Van Laere syndrome). J Neurol Sci (1981) 1.29
Intracranial reticulum cell sarcoma associated with immunoglobulin A deficiency. J Neurol Neurosurg Psychiatry (1973) 1.28
Ultrastructure of anterior horn motor neurones in the Hirano-Kurland-Sayre type of combined neurological system degeneration. J Neurol Sci (1971) 1.27
Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (1999) 1.26
Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review. J Clin Immunol (1992) 1.26
Improved function with amino acids in the isolated perfused kidney. Am J Physiol (1982) 1.23
Inhibition of pyruvate and beta-hydroxybutyrate oxidation in rat brain mitochondria by phenylpyruvate and alpha-ketoisocaproate. FEBS Lett (1974) 1.22
A mitochondrial myopathy with a deficiency of respiratory chain NADH-CoQ reductase activity. J Neurol Sci (1979) 1.21
Migraine and reporoductive hormones throughout the menstrual cycle. Lancet (1975) 1.19
Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo. Gene Ther (1998) 1.19
Development of mitochondrial energy metabolism in rat brain. Biochem J (1977) 1.16
Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione. Free Radic Biol Med (1996) 1.14
Assessment of the role of the glutathione and pentose phosphate pathways in the protection of primary cerebrocortical cultures from oxidative stress. J Neurochem (1996) 1.14
Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med (1994) 1.13
Late onset heterozygous ornithine transcarbamylase deficiency mimicking complex partial status epilepticus. J Neurol Neurosurg Psychiatry (2000) 1.13
Differential effects of 2-oxo acids on pyruvate utilization and fatty acid synthesis in rat brain. Biochem J (1974) 1.13
Immunocytochemical study of the cellular immune response in meningiomas. J Clin Pathol (1988) 1.13
Metabolic imaging of mild traumatic brain injury. Brain Imaging Behav (2012) 1.12
The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model. Gene Ther (2002) 1.12
Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol Dis (2002) 1.10
In vivo magnetic resonance imaging of hyperpolarized silicon particles. Nat Nanotechnol (2013) 1.08
Growth kinetics and treatment response of the intracerebral rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging. Clin Cancer Res (1995) 1.07
Spinal cord degeneration in divers. Lancet (1987) 1.07
Effect of inhibition of gluconeogenesis on ammonia production in the perfused rat kidney. Clin Sci Mol Med (1976) 1.07
Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol (1987) 1.07
Early castration reduces prostatic carcinogenesis in transgenic mice. Urology (1999) 1.07
Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by (13)C MRS and [1-(13)C]glucose infusion. J Neurochem (2001) 1.05
Migraine and its equivalents in childhood. Dev Med Child Neurol (1987) 1.05
Clinical magnetic susceptibility mapping of the brain. J Comput Assist Tomogr (1987) 1.04
The effect of experimental bile-duct obstruction on critical biosynthetic functions of the liver. Br J Surg (1972) 1.04
Pathology of amyotrophic lateral sclerosis. Adv Neurol (1982) 1.03
Evidence for increased nitric oxide production in multiple sclerosis. J Neurol Neurosurg Psychiatry (1995) 1.03
Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study. J Clin Invest (1995) 1.03
1-(13)C glucose magnetic resonance spectroscopy of pediatric and adult brain disorders. NMR Biomed (2001) 1.03
Activation of oxoglutarate dehydrogenase in the kidney in response to acute acidosis. Biochem J (1980) 1.02
Peroxynitrite and brain mitochondria: evidence for increased proton leak. J Neurochem (1998) 1.02
The mononuclear cell infiltrate compared with survival in high-grade astrocytomas. Acta Neuropathol (1989) 1.02
Three methods of calibration in quantitative proton MR spectroscopy. J Magn Reson B (1995) 1.02
Role of increased cerebral myo-inositol in the dementia of Down syndrome. Magn Reson Med (1995) 1.01
Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice. J Urol (1998) 1.00
Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas. J Neurooncol (2001) 0.99
Age dependent changes in the cerebrospinal fluid concentration of nitrite and nitrate. Ann Clin Biochem (1996) 0.99
Selective distal nephron damage during isolated kidney perfusion. Kidney Int (1981) 0.98
A 15N-n.m.r. study of cerebral, hepatic and renal nitrogen metabolism in hyperammonaemic rats. Biochem J (1990) 0.98
The importance of pH in renal preservation. Transplant Proc (1981) 0.98
[1-13C]glucose MRS in chronic hepatic encephalopathy in man. Magn Reson Med (2001) 0.98
Tetrahydrobiopterin deficiency and brain nitric oxide synthase in the hph1 mouse. J Inherit Metab Dis (1995) 0.97
Pathology of peroneal muscular atrophy (Charcot-Marie-Tooth disease). J Neurol Neurosurg Psychiatry (1972) 0.97
Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases. Neurology (1998) 0.97